Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC000459 dose-finding study in mild to moderate persistent asthma
2008-006013-24Phase 2Completed
- Sponsor
- Oxagen
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of timapiprant in asthma and persistent asthma (4 arms), sponsored by Oxagen. Primary endpoint: Change from baseline in clinic FEV1 over double-blind treatment. Started Jan 2009; status: completed.
02
Drugs
timapiprant
03
Conditions
asthmapersistent asthma
Beyond the preview
Go deeper on 2008-006013-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006013-24.